Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Microorganism overgrowth and hyperkeratosis may trigger immune reactions causing lichen planopilaris.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

Human hair follicle stem cells help repair tendon injuries.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Certain IL-18 gene variations may increase the risk of alopecia areata.

Blocking certain immune signals can reduce skin damage from radiation therapy.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Some antiseizure medications can cause cosmetic problems like hair loss, excessive hair growth, acne, and gum overgrowth.

Different genes are active in dogs' hair growth and skin, similar to humans, which helps understand dog skin and hair diseases and can relate to human conditions.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.